|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01789 AK MEDICAL
Nominal 
5.360 -0.020 (-0.372%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 1,093,862 | 3.975% | 1,052,047 | 761,441 | 1,035,386 | 926,705 |
| Cost of Sales | (419,376) | 0.906% | (415,612) | (262,252) | (320,854) | (283,454) |
| Gross Profit | 674,486 | 5.979% | 636,435 | 499,189 | 714,532 | 643,251 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (18,360) | -- | (8,848) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 231,117 | -3.817% | 240,290 | 108,559 | 376,607 | 321,402 | |
| Taxation | (49,013) | 37.995% | (35,518) | (15,940) | (62,600) | (54,410) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 182,104 | -11.070% | 204,772 | 92,619 | 314,007 | 266,992 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (19,634) | -3.314% | (20,307) | (9,123) | (7,681) | (5,881) |
| Depreciation & Amortisation | 90,939 | 13.107% | 80,401 | 74,158 | 60,521 | 32,157 |
| Directors' Emoluments | 4,580 | 6.339% | 4,307 | 3,746 | 3,150 | 6,045 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 16.000 | -11.111% | 18.000 | 8.000 | 28.000 | 26.000 |
| DPS (cts) | 4.082 | -- | 5.226 | 2.037 | 3.350 | 6.766 |
| Dividend Payout Ratio (%) | 25.510% | -- | 29.036% | 25.460% | 11.964% | 26.024% |
| Cash flow per share ($) | 0.030 | -- | 0.219 | 0.159 | 0.186 | 0.139 |
| NBV per share ($) | 2.132 | -- | 2.011 | 1.821 | 1.831 | 1.060 |
| Remarks: | Real time quote last updated: 29/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 139,253,000 |
| %Change | 5.038% |
| EPS / (LPS) | RMB 0.120 |
| NBV Per Share (¥) | RMB 2.219 |